EMPIRIC ANTIFUNGAL THERAPY IN PATIENTS WITH FEBRILE NEUTROPENIA

被引：0
|
作者：
Nucci, M. [1 ]
机构：
[1] Univ Fed Rio de Janeiro, Hosp Univ Clementino Fraga Filho, Dept Clin Med, Serv Hematol & Lab Micol, BR-21941 Rio De Janeiro, Brazil
来源：
DRUGS OF TODAY | 2010年 / 46卷
关键词：
CLINICAL-PRACTICE GUIDELINES; INFECTIOUS-DISEASES SOCIETY; INVASIVE MOLD INFECTION; HIGH-RISK; COMPUTED-TOMOGRAPHY; ASPERGILLOSIS; GALACTOMANNAN; MANAGEMENT;
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：13 / 20
页数：8
相关论文
共 50 条
  • [31] Micafungin for empirical antifungal therapy in patients with febrile neutropenia: multicenter phase 2 study
    Mizuno, Hiroki
    Sawa, Masashi
    Yanada, Masamitsu
    Shirahata, Mizuho
    Watanabe, Masato
    Kato, Tomonori
    Nagai, Hirokazu
    Ozawa, Yukiyasu
    Morishita, Takanobu
    Tsuzuki, Motohiro
    Goto, Emi
    Tsujimura, Akane
    Suzuki, Ritsuro
    Atsuta, Yoshiko
    Emi, Nobuhiko
    Naoe, Tomoki
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2013, 98 (02) : 231 - 236
  • [32] Micafungin, a novel antifungal agent, as empirical therapy in acute leukemia patients with febrile neutropenia
    Yanada, Masamitsu
    Kiyoi, Hitoshi
    Murata, Makoto
    Suzuki, Momoko
    Iwai, Masanori
    Yokozawa, Toshiya
    Baba, Hisashi
    Emi, Nobuhiko
    Naoe, Tomoki
    INTERNAL MEDICINE, 2006, 45 (05) : 259 - 264
  • [33] EVALUATING EFFICACY OF AN EMPIRIC ANTIBIOTIC REGIMEN IN PEDIATRIC PATIENTS WITH FEBRILE NEUTROPENIA
    Knight, Tristan
    Gupte, Avanti
    Dulay, Kristopher
    Mitchell, Robert
    Salimnia, Hossein
    Wang, Zhihong Joanne
    PEDIATRIC BLOOD & CANCER, 2019, 66
  • [34] Early Discontinuation of Empiric Antibiotic Therapy in Children Treated for Cancer with Febrile Neutropenia
    Papachristidou, S.
    Doganis, D.
    Kourlaba, G.
    Baka, M.
    Pourtsidis, A.
    Pantalos, G.
    Papaevangelou, V.
    Tsolia, M.
    Spyridis, N.
    PEDIATRIC BLOOD & CANCER, 2021, 68 : S73 - S73
  • [35] Comparison of Empiric Antibiotic Escalation Therapy with Vancomycin (VAN) versus Linezolid (LIN) in Patients with Febrile Neutropenia
    Mayer, Karin
    Hegge, Nicolaus
    Molitor, Ernst
    Brossart, Peter
    Hahn-Ast, Corinna
    MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES, 2022, 14
  • [36] Outpatient therapy in patients with febrile neutropenia
    Londono Gallo, Andres
    IATREIA, 2008, 21 (01) : 63 - 74
  • [37] A review of antibacterial and antifungal therapy in the febrile child with neutropenia induced by antineoplastic therapy
    Chanock, SJ
    INTERNATIONAL JOURNAL OF PEDIATRIC HEMATOLOGY/ONCOLOGY, 1997, 4 (05): : 459 - 472
  • [38] Efficacy and safety of micafungin in empiric and D-index-guided early antifungal therapy for febrile neutropenia; A subgroup analysis of the CEDMIC trial
    Kimura, Shun-ichi
    Kanda, Yoshinobu
    Iino, Masaki
    Fukuda, Takahiro
    Sakaida, Emiko
    Oyake, Tatsuo
    Yamaguchi, Hiroki
    Fujiwara, Shin-ichiro
    Jo, Yumi
    Okamoto, Akinao
    Fujita, Hiroyuki
    Takamatsu, Yasushi
    Saburi, Yoshio
    Matsumura, Itaru
    Yamanouchi, Jun
    Shiratori, Souichi
    Gotoh, Moritaka
    Nakamura, Shingen
    Tamura, Kazuo
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2020, 100 : 292 - 297
  • [39] Pre-emptive antifungal therapy versus empirical antifungal therapy for febrile neutropenia in people with cancer
    Uneno, Yu
    Imura, Haruki
    Makuuchi, Yosuke
    Tochitani, Kentaro
    Watanabe, Norio
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2022, (11):
  • [40] Empiric antifungal therapy in neutropenic cancer patients
    Rotstein C.
    Current Infectious Disease Reports, 2006, 8 (1) : 7 - 13
12345